MBX
MBX Biosciences Inc.
$29.86
+$1.43(+5.03%)
56
Overall
60
Value
66
Tech
44
Quality
Market Cap
$34.31M
Volume
450.41K
52W Range
$4.81 - $34.83
Target Price
$62.29
Company Overview
| Mkt Cap | $34.31M | Price | $29.86 |
| Volume | 450.41K | Change | +5.03% |
| P/E Ratio | -0.6 | Open | $28.76 |
| Revenue | -- | Prev Close | $28.43 |
| Net Income | $-61.9M | 52W Range | $4.81 - $34.83 |
| Div Yield | N/A | Target | $62.29 |
| Overall | 56 | Value | 60 |
| Quality | 44 | Technical | 66 |
No chart data available
Latest News
Microbix Biosystems to Announce Q4 2025 Financial Results
TipRanks Canadian Auto-Generated Newsdesk•2 days ago
Microbix Biosystems Launches New Products to Enhance H3N2 Flu Testing
TipRanks Canadian Auto-Generated Newsdesk•4 days ago
MBX Biosciences, Inc. (MBX) Gets a Buy from Guggenheim
TipRanks Auto-Generated Intelligence Newsdesk•9 days ago
Microbix and Seegene Mexico Collaborate to Enhance HPV Test Accuracy
TipRanks Canadian Auto-Generated Newsdesk•11 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MBX | $29.86 | +5.0% | 450.41K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |